{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:49:32Z","timestamp":1785419372831,"version":"3.56.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009757","name":"H.K.H. Kronprinsessan Lovisas F\u00f6rening f\u00f6r Barnasjukv\u00e5rd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic Ovary Syndrome (PCOS) is an endocrine disorder that affects women in reproductive age and represents an unfavourable risk factor for several pregnancy and perinatal outcomes. Despite, no guidelines or pharmaceutical strategies for treating PCOS during pregnancy are available. The aim of this study is to determine the association between polycystic ovary syndrome with or without metformin and the pregnancy, perinatal outcomes as well as the risk of obesity in children born to these mothers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this nationwide population-based cohort study based in Swedish population, all singleton births (<jats:italic>n<\/jats:italic>\u00a0=\u20091,016,805) from 686,847 women since 2006 up to 2016 were included. Multivariable logistic and Cox regression modelling with odds ratios (OR) and hazard ratios (HR) and 95% confidence intervals were used to study the association between the exposure of maternal PCOS, metformin during pregnancy (or the combination of both) and: 1) Pregnancy outcomes: preeclampsia, gestational diabetes, caesarean section, and acute caesarean section, 2) Perinatal outcomes: preterm birth, stillbirth, low birth weight, macrosomia, Apgar &lt;\u20097 at 5\u2009min, small for gestational age and large for gestational age, and 3) Childhood Obesity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PCOS in women without metformin use during pregnancy was associated with higher risks of preeclampsia (OR\u2009=\u20091.09, 1.02\u20131.17), gestational diabetes (OR\u2009=\u20091.71, 1.53\u20131.91) and caesarean section (OR\u2009=\u20091.08, 1.04\u20131.12), preterm birth (OR\u2009=\u20091.30, 1.23\u20131.38), low birth weight (OR\u2009=\u20091.29, 1.20\u20131.38), low Apgar scores (OR\u2009=\u20091.17, 1.05\u20131.31) and large for gestational age (OR\u2009=\u20091.11, 1.03\u20131.20). Metformin use during pregnancy (in women without PCOS) was associated with a 29% lower risks of preeclampsia (OR\u2009=\u20090.71, 0.51\u20130.97), macrosomia and large for gestational age. Obesity was more common among children born to mothers with PCOS without metformin (HR\u2009=\u20091.61, 1.44\u20131.81); and those with metformin without PCOS (HR\u2009=\u20091.67, 1.05\u20132.65). PCOS with metformin was not associated with any adverse outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PCOS was associated with increased risks of adverse pregnancy and perinatal outcomes and childhood obesity. Metformin appears to reduce these risks in mothers with polycystic ovary syndrome and their children; but may increase the risk of childhood-obesity in children form women without PCOS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-022-00905-6","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T07:09:09Z","timestamp":1644217749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study"],"prefix":"10.1186","volume":"20","author":[{"given":"Romina","family":"Fornes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Simin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Hanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Crisosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Engstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-447X","authenticated-orcid":false,"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"issue":"11","key":"905_CR1","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijerph15112589","volume":"15","author":"WM Wolf","year":"2018","unstructured":"Wolf WM, et al. Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. Int J Environ Res Public Health. 2018;15(11):2589.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"905_CR2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1089\/jwh.2016.5792","volume":"26","author":"L Brennan","year":"2017","unstructured":"Brennan L, et al. Lifestyle and behavioral management of polycystic ovary syndrome. J Women's Health (Larchmt). 2017;26(8):836\u201348.","journal-title":"J Women's Health (Larchmt)"},{"issue":"6","key":"905_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/humupd\/dmu037","volume":"20","author":"VN Sivalingam","year":"2014","unstructured":"Sivalingam VN, et al. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update. 2014;20(6):853\u201368.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"905_CR4","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1093\/humrep\/dem271","volume":"22","author":"B Trolle","year":"2007","unstructured":"Trolle B, et al. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial. Hum Reprod. 2007;22(11):2967\u201373.","journal-title":"Hum Reprod"},{"issue":"10","key":"905_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41574-018-0081-6","volume":"14","author":"E Vanky","year":"2018","unstructured":"Vanky E, Odegard R. Metformin in pregnancy - safe or sorry? Nat Rev Endocrinol. 2018;14(10):570\u20132.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"905_CR6","first-page":"265","volume":"10","author":"A Jamal","year":"2012","unstructured":"Jamal A, Milani F, Al-Yasin A. Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran J Reprod Med. 2012;10(3):265\u201370.","journal-title":"Iran J Reprod Med"},{"issue":"1","key":"905_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1185\/03007995.2012.755121","volume":"29","author":"CJ Glueck","year":"2013","unstructured":"Glueck CJ, et al. Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome. Curr Med Res Opin. 2013;29(1):55\u201362.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"905_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","volume":"157","author":"V De Leo","year":"2011","unstructured":"De Leo V, et al. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):63\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"905_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","volume":"3","author":"C Chiswick","year":"2015","unstructured":"Chiswick C, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015;3(10):778\u201386.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"905_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS L\u00f8vvik","year":"2019","unstructured":"L\u00f8vvik TS, et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(4):256\u201366.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"905_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"Hanem LGE, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166\u201374.","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"905_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/00365513.2012.712319","volume":"72","author":"TB Ro","year":"2012","unstructured":"Ro TB, et al. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest. 2012;72(7):570\u20135.","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"905_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0038-1642632","volume":"40","author":"WB Sales","year":"2018","unstructured":"Sales WB, et al. Effectiveness of metformin in the prevention of gestational diabetes mellitus in obese pregnant women. Rev Bras Ginecol Obstet. 2018;40(4):180\u20137.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"5","key":"905_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434\u201343.","journal-title":"N Engl J Med"},{"issue":"12","key":"905_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/pds.4907","volume":"28","author":"SN Landi","year":"2019","unstructured":"Landi SN, et al. Comparative effectiveness of metformin versus insulin for gestational diabetes in New Zealand. Pharmacoepidemiol Drug Saf. 2019;28(12):1609\u201319.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"19","key":"905_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003\u201315.","journal-title":"N Engl J Med"},{"issue":"2","key":"905_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12020-019-02043-3","volume":"66","author":"R Bettencourt-Silva","year":"2019","unstructured":"Bettencourt-Silva R, et al. Metformin in overweight and obese women with gestational diabetes: a propensity score-matched study. Endocrine. 2019;66(2):192\u2013200.","journal-title":"Endocrine"},{"issue":"8","key":"905_CR18","doi-asserted-by":"publisher","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 2019;16(8):e1002848.","journal-title":"PLoS Med"},{"key":"905_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.reprotox.2018.07.004","volume":"81","author":"S Scherneck","year":"2018","unstructured":"Scherneck S, et al. Pregnancy outcome after first-trimester exposure to metformin: a prospective cohort study. Reprod Toxicol. 2018;81:79\u201383.","journal-title":"Reprod Toxicol"},{"issue":"3","key":"905_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1464-5491.2006.01750.x","volume":"23","author":"RC Hughes","year":"2006","unstructured":"Hughes RC, Rowan JA. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome? Diabet Med. 2006;23(3):318\u201322.","journal-title":"Diabet Med"},{"issue":"2","key":"905_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/dme.13523","volume":"35","author":"A Alqudah","year":"2018","unstructured":"Alqudah A, et al. Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis. Diabet Med. 2018;35(2):160\u201372.","journal-title":"Diabet Med"},{"issue":"4","key":"905_CR22","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/jc.2017-02419","volume":"103","author":"LGE Hanem","year":"2018","unstructured":"Hanem LGE, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"905_CR23","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team, R.F.f.S.C","year":"2020","unstructured":"R Core Team, R.F.f.S.C, R: A Language and Environment for Statistical Computing. 2020."},{"issue":"6","key":"905_CR24","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/01443615.2017.1410532","volume":"38","author":"C Fux-Otta","year":"2018","unstructured":"Fux-Otta C, et al. Pregnancy outcomes in women with polycystic ovary syndrome in two Latin American populations. J Obstet Gynaecol. 2018;38(6):750\u20135.","journal-title":"J Obstet Gynaecol"},{"issue":"7","key":"905_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, et al. The new Swedish prescribed drug register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"905_CR26","doi-asserted-by":"publisher","first-page":"d6309","DOI":"10.1136\/bmj.d6309","volume":"343","author":"N Roos","year":"2011","unstructured":"Roos N, et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ. 2011;343:d6309.","journal-title":"BMJ"},{"issue":"1","key":"905_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijgo.2008.01.023","volume":"102","author":"A Lindholm","year":"2008","unstructured":"Lindholm A, et al. Prevalence of symptoms associated with polycystic ovary syndrome. Int J Gynaecol Obstet. 2008;102(1):39\u201343.","journal-title":"Int J Gynaecol Obstet"},{"key":"905_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.","journal-title":"BMC Med"},{"issue":"10","key":"905_CR29","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/humrep\/dez159","volume":"34","author":"S Persson","year":"2019","unstructured":"Persson S, et al. Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study. Hum Reprod. 2019;34(10):2052\u201360.","journal-title":"Hum Reprod"},{"key":"905_CR30","volume-title":"The prevalence of overweight and obesity among children is high and increases with age","author":"Folkh\u00e4lsomyndigheten, P.h.a.o.S","year":"2019","unstructured":"Folkh\u00e4lsomyndigheten, P.h.a.o.S, The prevalence of overweight and obesity among children is high and increases with age. 2019."},{"issue":"1","key":"905_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12884-019-2547-5","volume":"19","author":"H Fadl","year":"2019","unstructured":"Fadl H, et al. Changing diagnostic criteria for gestational diabetes in Sweden - a stepped wedge national cluster randomised controlled trial - the CDC4G study protocol. BMC Pregnancy Childbirth. 2019;19(1):398.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"905_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2393-14-185","volume":"14","author":"M Lindqvist","year":"2014","unstructured":"Lindqvist M, et al. No consensus on gestational diabetes mellitus screening regimes in Sweden: pregnancy outcomes in relation to different screening regimes 2011 to 2012, a cross-sectional study. BMC Pregnancy Childbirth. 2014;14(1):185.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"905_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41387-020-0107-8","volume":"10","author":"Y Feng","year":"2020","unstructured":"Feng Y, et al. Stress adaptation is associated with insulin resistance in women with gestational diabetes mellitus. Nutrition Diabetes. 2020;10(1):4.","journal-title":"Nutrition Diabetes"},{"issue":"8","key":"905_CR34","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1093\/humrep\/dei009","volume":"20","author":"T Sir-Petermann","year":"2005","unstructured":"Sir-Petermann T, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod. 2005;20(8):2122\u20136.","journal-title":"Hum Reprod"},{"issue":"6","key":"905_CR35","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1097\/AOG.0000000000000852","volume":"125","author":"DA Doherty","year":"2015","unstructured":"Doherty DA, et al. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397\u2013406.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"905_CR36","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1210\/jc.2014-1214","volume":"99","author":"S Palomba","year":"2014","unstructured":"Palomba S, et al. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. J Clin Endocrinol Metab. 2014;99(8):2942\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"905_CR37","doi-asserted-by":"publisher","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","volume":"204","author":"LE Kjerulff","year":"2011","unstructured":"Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol. 2011;204(6):558.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"905_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba S, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575\u201392.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"905_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/obr.12829","volume":"20","author":"MB Khomami","year":"2019","unstructured":"Khomami MB, et al. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-a systematic review, meta-analysis, and meta-regression. Obes Rev. 2019;20(5):659\u201374.","journal-title":"Obes Rev"},{"issue":"5","key":"905_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/1471-0528.12558","volume":"121","author":"KV Naver","year":"2014","unstructured":"Naver KV, et al. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG Int J Obstet Gynaecol. 2014;121(5):575\u201381.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"1","key":"905_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejogrb.2009.11.010","volume":"149","author":"P Altieri","year":"2010","unstructured":"Altieri P, et al. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):31\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"905_CR42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/obr.12832","volume":"20","author":"M Bahri Khomami","year":"2019","unstructured":"Bahri Khomami M, et al. The role of maternal obesity in infant outcomes in polycystic ovary syndrome-a systematic review, meta-analysis, and meta-regression. Obes Rev. 2019;20(6):842\u201358.","journal-title":"Obes Rev"},{"issue":"4","key":"905_CR43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mefs.2011.09.001","volume":"16","author":"AA Nouh","year":"2011","unstructured":"Nouh AA, Shalaby SM. The predictive value of uterine blood flow in detecting the risk of adverse pregnancy outcome in patients with polycystic ovary syndrome. Middle East Fertil Soc J. 2011;16(4):284\u201390.","journal-title":"Middle East Fertil Soc J"},{"issue":"10","key":"905_CR44","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/1471-0528.13339","volume":"122","author":"TS Lovvik","year":"2015","unstructured":"Lovvik TS, et al. Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study. BJOG. 2015;122(10):1295\u2013302.","journal-title":"BJOG"},{"issue":"2","key":"905_CR45","first-page":"141","volume":"69","author":"C Klevedal","year":"2017","unstructured":"Klevedal C, Turkmen S. Fetal-maternal outcomes and complications in pregnant women with polycystic ovary syndrome. Minerva Ginecol. 2017;69(2):141\u20139.","journal-title":"Minerva Ginecol"},{"issue":"5","key":"905_CR46","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/AOG.0000000000001097","volume":"126","author":"CM Scifres","year":"2015","unstructured":"Scifres CM, et al. Large-for-gestational-age ultrasound diagnosis and risk for cesarean delivery in women with gestational diabetes mellitus. Obstet Gynecol. 2015;126(5):978\u201386.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"905_CR47","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"Feig DS, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2020;8(10):834\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"905_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1464-5491.2004.01251.x","volume":"21","author":"CJ Glueck","year":"2004","unstructured":"Glueck CJ, et al. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med. 2004;21(8):829\u201336.","journal-title":"Diabet Med"},{"issue":"8","key":"905_CR49","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/humrep\/deh347","volume":"19","author":"E Vanky","year":"2004","unstructured":"Vanky E, et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004;19(8):1734\u201340.","journal-title":"Hum Reprod"},{"issue":"6","key":"905_CR50","first-page":"Cd012394","volume":"6","author":"RJ Griffith","year":"2020","unstructured":"Griffith RJ, et al. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2020;6(6):Cd012394.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"905_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jog.13477","volume":"44","author":"E Vald\u00e9s","year":"2018","unstructured":"Vald\u00e9s E, et al. Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: a randomized study. J Obstet Gynaecol Res. 2018;44(1):81\u20136.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"905_CR52","doi-asserted-by":"publisher","first-page":"e000456","DOI":"10.1136\/bmjdrc-2017-000456","volume":"6","author":"JA Rowan","year":"2018","unstructured":"Rowan JA, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018;6(1):e000456.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"905_CR53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jamapediatrics.2018.4214","volume":"173","author":"SN Landi","year":"2019","unstructured":"Landi SN, et al. Association of Long-term Child Growth and Developmental Outcomes with Metformin vs insulin treatment for gestational diabetes. JAMA Pediatr. 2019;173(2):160\u20138.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"905_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/gye.17.1.51.56","volume":"17","author":"T Kazerooni","year":"2003","unstructured":"Kazerooni T, Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Gynecol Endocrinol. 2003;17(1):51\u20136.","journal-title":"Gynecol Endocrinol"},{"key":"905_CR55","doi-asserted-by":"publisher","first-page":"5150684","DOI":"10.1155\/2020\/5150684","volume":"2020","author":"Y Guan","year":"2020","unstructured":"Guan Y, et al. The effect of metformin on polycystic ovary syndrome in overweight women: a systematic review and Meta-analysis of randomized controlled trials. Int J Endocrinol. 2020;2020:5150684.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"905_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fertnstert.2011.10.002","volume":"97","author":"N Crisosto","year":"2012","unstructured":"Crisosto N, et al. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. Fertil Steril. 2012;97(1):218\u201324.","journal-title":"Fertil Steril"},{"issue":"10","key":"905_CR57","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15(10):569\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"7436","key":"905_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","volume":"494","author":"RA Miller","year":"2013","unstructured":"Miller RA, et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 2013;494(7436):256\u201360.","journal-title":"Nature"},{"issue":"3","key":"905_CR59","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","volume":"217","author":"R Romero","year":"2017","unstructured":"Romero R, et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol. 2017;217(3):282\u2013302.","journal-title":"Am J Obstet Gynecol"},{"key":"905_CR60","doi-asserted-by":"publisher","first-page":"341583","DOI":"10.1155\/2015\/341583","volume":"2015","author":"AA Thorp","year":"2015","unstructured":"Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res. 2015;2015:341583.","journal-title":"J Diabetes Res"},{"issue":"15","key":"905_CR61","first-page":"3482","volume":"21","author":"G Medina","year":"2017","unstructured":"Medina G, et al. Metformin increases norepinephrine transporter expression in placenta of patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2017;21(15):3482\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"905_CR62","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.19082\/5969","volume":"9","author":"F Foroozanfard","year":"2017","unstructured":"Foroozanfard F, et al. Effect of metformin on the anti-M\u00fcllerian hormone level in infertile women with polycystic ovarian syndrome. Electron Physician. 2017;9(12):5969\u201373.","journal-title":"Electron Physician"},{"issue":"4","key":"905_CR63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4103\/jhrs.JHRS_59_17","volume":"11","author":"N Chhabra","year":"2018","unstructured":"Chhabra N, Malik S. Effect of insulin sensitizers on raised serum anti-mullerian hormone levels in infertile women with polycystic ovarian syndrome. J Hum Reprod Sci. 2018;11(4):348\u201352.","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"905_CR64","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.fertnstert.2018.11.028","volume":"111","author":"TT Piltonen","year":"2019","unstructured":"Piltonen TT, et al. Circulating antim\u00fcllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term. Fertil Steril. 2019;111(3):588\u2013596.e1.","journal-title":"Fertil Steril"},{"issue":"6","key":"905_CR65","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata B, et al. Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med. 2018;24(6):834\u201346.","journal-title":"Nat Med"},{"issue":"3","key":"905_CR66","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni NEH, et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 2021;33(3):513\u2013530.e8.","journal-title":"Cell Metab"},{"issue":"6","key":"905_CR67","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00125-019-4848-7","volume":"62","author":"T Bryrup","year":"2019","unstructured":"Bryrup T, et al. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. Diabetologia. 2019;62(6):1024\u201335.","journal-title":"Diabetologia"},{"issue":"2","key":"905_CR68","doi-asserted-by":"publisher","first-page":"bvaa177","DOI":"10.1210\/jendso\/bvaa177","volume":"5","author":"MG Rizk","year":"2021","unstructured":"Rizk MG, Thackray VG. Intersection of polycystic ovary syndrome and the gut microbiome. J Endocr Soc. 2021;5(2):bvaa177.","journal-title":"J Endocr Soc"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-00905-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T03:26:33Z","timestamp":1666581993000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-00905-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-00905-6","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical permission was granted by the Regional Ethics Review Board in Stockholm (2017\/2423\u201331) without the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"all authors consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}